Clovis Oncology, Inc. Business Finance Contracts & Agreements

Asset Purchase Agreement, dated as of April 5, 2023, by and between Clovis Oncology, Inc. and pharma& Schweiz GmbH (Filed With SEC on April 6, 2023)

Pledge and Security Agreement, dated as of January 6, 2023, by and among the Company certain subsidiaries of the Company, as grantors, and the Administrative Agent (Filed With SEC on January 12, 2023)

Secured Superpriority Debtor-In-Possession Financing Agreement, dated as of January 6, 2023, by and among the Company, as borrower, Clovis Ireland and Clovis UK, as guarantors,... (Filed With SEC on January 12, 2023)

DIP Term Sheet (Filed With SEC on December 19, 2022)

Purchase and Assignment Agreement, dated as of December 11, 2022, by and between Clovis Oncology, Inc. and Novartis Innovative Therapies AG (Filed With SEC on December 13, 2022)

Clovis Oncology, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 4, 2021)

Indenture, dated as of November 17, 2020, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes (Filed With SEC on November 17, 2020)

Form of Exchange and Purchase Agreement (Filed With SEC on November 5, 2020)

Form of Indenture, to be entered into by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes (Filed With SEC on November 5, 2020)

Underwriting Agreement, dated May 18, 2020 (Filed With SEC on May 21, 2020)

Indenture, dated as of August 13, 2019, by and between Clovis Oncology, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on August 13, 2019)

Financing Agreement, dated as of May 1, 2019 among Clovis Oncology, Inc. (the Company), certain subsidiaries of the Company named therein, as Guarantors, the Lenders from time to... (Filed With SEC on May 2, 2019)

Pledge and Security Agreement, dated as of May 1, 2019 among each of the Grantors party thereto and the Administrative Agent party thereto (Filed With SEC on May 2, 2019)

Clovis Oncology, Inc. 2011 Employee Stock Purchase Plan, as amended (Filed With SEC on August 2, 2018)

First Supplemental Indenture, dated April 19, 2018 (Filed With SEC on April 19, 2018)

Indenture, dated April 19, 2018 (Filed With SEC on April 19, 2018)

Underwriting Agreement, dated April 16, 2018 (Filed With SEC on April 19, 2018)

CLOVIS ONCOLOGY, INC. 3,409,091Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on June 26, 2017)

RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT (Filed With SEC on February 23, 2017)

CLOVIS ONCOLOGY, INC. 5,000,000Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on January 9, 2017)

CLOVISONCOLOGY, INC. 3,525,641 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on July 14, 2015)

CLOVISONCOLOGY, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of September 9, 2014 2.50% Convertible Senior Notes due 2021 TABLE OF... (Filed With SEC on September 9, 2014)

CLOVISONCOLOGY, INC. 2,000,000 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on December 9, 2013)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Development and Commercialization Agreement by and... (Filed With SEC on November 19, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 19, 2013)

STOCK PURCHASE AGREEMENT by and among CLOVISONCOLOGY, INC., EOS (ETHICAL ONCOLOGY SCIENCE) S.P.A., THE SELLERS LISTED ON EXHIBIT A HERETO, and SOFINNOVA CAPITALV FCPR, as the... (Filed With SEC on November 19, 2013)

CLOVIS ONCOLOGY, INC. 3,333,334 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on June 17, 2013)

CLOVIS ONCOLOGY, INC. [ ] Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on March 30, 2012)